Source: Research Seminar 2014 - Protein quality control in lung disease



Rating:

Share or cite this content

Citations should be made in the following way:
M. Ljujic (Belgrade, Serbia), Young Scientist. Alpha-1 antitrypsin: functional analysis of novel variants. Research Seminar 2014 - Protein quality control in lung disease

Member's Comments

No comment yet.

Related content which might interest you: Molecular characterization of novel PiS-like alleles identified in Spanish patients with Alpha-1 antitrypsin deficiency Source: International Congress 2018 – Functional genomics and COPD: new challenges Year: 2018 Structural and clinical characterization of novel missense variants of SERPINA1 gene causing alpha-1 antitrypsin deficiency Source: International Congress 2019 – Crosstalk in chronic pulmonary diseases Year: 2019 Alpha-1 antitrypsin deficiency: clarifying the role of the putative protective threshold Source: Eur Respir J, 59 (2) 2101410; 10.1183/13993003.01410-2021 Year: 2022 microRNA regulation of the alpha-1 antitrypsin gene Source: Annual Congress 2011 - New mechanisms in airway disease Year: 2011 A new SERPINA-1 missense mutation associated with alpha-1 antitrypsin deficiency and bronchiectasis. Source: International Congress 2017 – Current molecular and genetic understanding of lung diseases Year: 2017 PiS and PiS-plus alleles. The importance of phasing gene variants in Alpha-1 Antitrypsin Deficiency Source: Virtual Congress 2020 – Intercellular communication in tissue remodelling of chronic lung diseases Year: 2020 Rare alpha-1 antitrypsin mutations in the Irish population Source: Annual Congress 2011 - Genetic and environmental risk factors for respiratory diseases Year: 2011 Rare alpha-1 antitrypsin mutations in the Irish population Source: Annual Congress 2012 - COPD inflammation and genes Year: 2012 GSTP1 polymorphisms in patients with COPD and alpha-1 antitrypsin deficiency Source: Eur Respir J 2003; 22: Suppl. 45, 384s Year: 2003 Functional alterations of small airways in patients with alpha-1 antitrypsin deficiency (AATD) in a longitudinal study Source: Eur Respir J 2005; 26: Suppl. 49, 361s Year: 2005 Pilot study for detection of alpha-1 antitrypsin deficiency in a targeted Argentinean population Source: Eur Respir J 2005; 26: Suppl. 49, 59s Year: 2005 Alpha-1 antitrypsin deficiency severity and the risk of COVID-19 Source: Virtual Congress 2021 – Burden and epidemiology of COVID-19 Year: 2021 A high purity alpha-1 antitrypsin (AAT) from human plasma, TAL6004 Source: Annual Congress 2009 - Treatment of airways disease Year: 2009 Characterisation of alpha-1 antitrypsin protein expression and secretion in natural killer cells from healthy volunteers and alpha-1 antitrypsin deficiency patients Source: Virtual Congress 2021 – Novel insights into the pathogenesis of chronic lung diseases Year: 2021 A well-designed/conducted study on alpha-1 antitrypsin epidemiology not quoted Source: Eur Respir J, 51 (3) 1702662; 10.1183/13993003.02662-2017 Year: 2018 Therapeutic efficacy of alpha-1 antitrypsin (AAT) augmentation therapy on the loss of lung tissue: an integrated analysis Source: Annual Congress 2008 - Recent advances in the pathogenesis and treatment of asthma and COPD Year: 2008 Alpha-1 antitrypsin deficiency – a potentially fatal disease Source: International Congress 2017 – Rare and common genetic variants of common and rare airway diseases Year: 2017 Alpha-1 antitrypsin (AAT) and alpha-2 macroglobulin (AMG) levels according to the stages and histological types in lung cancer Source: Annual Congress 2008 - Biology and prognosis in thoracic oncology Year: 2008